Rickard John, Popovic Zoran, Verhaert David, Sraow Dan, Baranowski Bryan, Martin David O, Lindsay Bruce D, Varma Niraj, Tchou Patrick, Grimm Richard A, Wilkoff Bruce L, Chung Mina K
Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Pacing Clin Electrophysiol. 2011 May;34(5):604-11. doi: 10.1111/j.1540-8159.2010.03022.x. Epub 2011 Jan 28.
The relationship between QRS narrowing and response to cardiac resynchronization therapy (CRT) has been controversial.
We sought to analyze the relationship between QRS narrowing and reverse remodeling in patients undergoing CRT, taking into account potential confounders including pre-CRT QRS duration and underlying QRS morphology.
We reviewed pre- and postimplant electrocardiograms and echocardiograms in a cohort of 233 patients undergoing the new implantation of a CRT device between December 2001 and September 2006. For inclusion in the final cohort, patients had New York Heart Association classes II-IV heart failure, left ventricular ejection fraction (LVEF) ≤ 40%, and QRS duration ≥120 ms. Response to CRT was defined as a reduction in left ventricular end-systolic volume (LVESV) of ≥10%. A multivariate model was constructed to determine the relationship between QRS change and response to CRT.
Patients with QRS narrowing had significantly greater reductions in left ventricular end-diastolic volume (LVEDV) (mL) (-26.5 ± 52.5 vs -4.8 ± 44.0, P = 0.002) and LVESV (mL) (-34.0 ± 55.5 vs -9.9 ± 45.8, P = 0.002) and improvement in LVEF (%) (8.9 ± 12.8 vs 4.5 ± 9.0, P = 0.007) than patients without narrowing. In univariate analysis, female gender (P = 0.0002), percent QRS narrowing from baseline (P = 0.008), lack of nitrate (P≤0.0001) and antiarrhythmic medication use (P = 0.01), lack of a nonspecific intraventricular conduction delay (=0.02), nonischemic cardiomyopathy (P = 0.003), and lower pre-CRT LVEDV (P = 0.006) and LVESV [P = 0.01]) were associated with responders. In a multivariate model, QRS narrowing, indexed to the baseline QRS duration, remained strongly associated with response (odds ratio 0.08 [0.01-0.56], P = 0.01).
After adjusting for potential confounders, QRS narrowing, indexed to baseline QRS duration, is associated with enhanced reverse ventricular remodeling following CRT.
QRS波变窄与心脏再同步治疗(CRT)反应之间的关系一直存在争议。
我们试图分析接受CRT治疗患者的QRS波变窄与逆向重构之间的关系,同时考虑包括CRT治疗前QRS波持续时间和潜在QRS波形态在内的潜在混杂因素。
我们回顾了2001年12月至2006年9月期间233例新植入CRT装置患者的植入前和植入后心电图及超声心动图。纳入最终队列的患者为纽约心脏协会II-IV级心力衰竭、左心室射血分数(LVEF)≤40%且QRS波持续时间≥120毫秒。CRT反应定义为左心室收缩末期容积(LVESV)减少≥10%。构建多变量模型以确定QRS波变化与CRT反应之间的关系。
与QRS波未变窄的患者相比,QRS波变窄的患者左心室舒张末期容积(LVEDV)(毫升)显著降低(-26.5±52.5对-4.8±44.0,P = 0.002),LVESV(毫升)显著降低(-34.0±55.5对-9.9±45.8,P = 0.002),LVEF(%)改善更明显(8.9±12.8对4.5±9.0,P = 0.007)。在单变量分析中,女性(P = 0.0002)、QRS波从基线变窄的百分比(P = 0.008)、未使用硝酸盐(P≤0.0001)和抗心律失常药物(P = 0.01)、不存在非特异性室内传导延迟(P = 0.02)、非缺血性心肌病(P = 0.003)以及较低的CRT治疗前LVEDV(P = 0.006)和LVESV(P = 0.01)与反应者相关。在多变量模型中,以基线QRS波持续时间为指标的QRS波变窄与反应仍密切相关(比值比0.08[0.01-0.56],P = 0.01)。
在调整潜在混杂因素后,以基线QRS波持续时间为指标的QRS波变窄与CRT治疗后增强的心室逆向重构相关。